Walgreens Boots Alliance has agreed to pay $300 million to settle allegations by the U.S. Department of Justice that it filled millions of invalid prescriptions for opioids and other controlled substances. The company also faced claims of illegally billing federal programs like Medicare for these medications, highlighting issues of accountability amid the opioid crisis.